Adalimumab drug survival in patients with psoriasis, Crohn's disease, and rheumatoid arthritis: Relevant differences using the same treatment.

Autor:	van den Reek JM; Department of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: Juul.vandenReek@Radboudumc.nl., Pijls PA; Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, The Netherlands., Tummers M; Radboud Institute for Health Sciences, Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands., van Riel PC; Scientific Institute for Quality of Healthcare, Radboud University Medical Center, Nijmegen, The Netherlands., Kievit W; Radboud Institute for Health Sciences, Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands., Hoentjen F; Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, The Netherlands., de Jong EM; Department of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands.
Jazyk:	angličtina
Zdroj:	Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2016 Jan; Vol. 74 (1), pp. 177-9.
DOI:	10.1016/j.jaad.2015.08.010
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect